ORGANIGRAM GLOBAL INC. (OGI) Form 6-K — Nov 3, 2026
Organigram Global (NASDAQ: OGI) has agreed to acquire Aurora Cannabis (NASDAQ: ACB) in a court-approved plan of arrangement valuing Aurora at approximately C$561 million, paying C$7.80 per Aurora share in cash, shares, or a mix, at Aurora shareholders' election subject to proration. The offer represents a 93% premium to Aurora's unaffected price and a 21% premium to the rejected Curaleaf hostile bid, with unanimous support from both boards and voting agreements from directors, officers, and BAT.
Key figures
- Debt Amount
- $210 million (ATB Financial senior secured loan facilities, including $115M Term Tranche 2)
- Deal Value Usd
- C$561 million (fully diluted equity value of Aurora)
- Interest Rate
- ATB benchmark rates plus margin based on net funded debt to EBITDA
- Maturity Date
- Three years after closing
- Gross Proceeds
- C$187.5 million (GBP 100,000,000 BAT private placement)
- Offering Price
- C$7.80 per Aurora common share
- Shares Offered
- 205826172
- Expected closing
- January 2027
- Max cash component
- C$253,638,772
- Identified synergies
- C$50 million+
- Share exchange ratio
- 5.8626 Organigram shares per Aurora share
- Aurora pro forma ownership
- ~35% economic / 42% voting
- Bat private placement price
- C$1.33 per Organigram share
- Premium to unaffected price
- 93%
- Bat private placement shares
- 141.0 million
- Combined cash plus share option
- C$3.75 cash plus 3.0431 Organigram shares
- Premium to curaleaf hostile bid
- 21%
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.